瑞典斯德哥尔摩。Wellma 是营养保健品和制药领域领先的欧洲开发和生产合作伙伴，宣布与德国 CDMO 和液体制剂脂质体技术的领先创新者 PlantaCorp 建立战略合作伙伴关系。

总部位于德国汉堡的PlantaCorp以其尖端研发和专有脂质体封装技术和旗下"ACTINOVO"品牌脂质体补充剂而闻名，该技术提高了活性成分的生物利用率。脂质体制剂通过保护磷脂层中的活性化合物来改善营养吸收，从而为消费者带来更高的疗效和更好的结果。凭借强大的科学基础、对质量的承诺和先进的制造运营，PlantaCorp 已成为营养保健品领域品牌值得信赖的合作伙伴。

“我们对这种合作伙伴关系将带来的机会感到兴奋，”PlantaCorp 的联合创始人兼首席执行官 Jan Braband 说。“通过与 Wellma 联手，我们可以扩大业务范围，加速创新，并携手合作，从而在为客户创造更多价值的同时实现更快的增长。”

正如 PlantaCorp 的联合创始人 Rinat Albetkov 所强调的那样，这种伙伴关系还代表了个人价值观和创业文化的一致性：“从我们与 Wellma 的第一次对话中，我们看到了对创新、人才、企业家精神和可持续增长的共同愿景。这种合作伙伴关系确保我们的技术、专业知识和创业文化继续蓬勃发展，同时也为我们开辟了令人兴奋的新机会。

Wellma 首席执行官 Christian Merup 分享了兴奋之情：“我们很高兴欢迎 PlantaCorp 加入 Wellma 大家庭。从一开始，我们就被他们先进的研发专业知识、他们的远见和强大的创业能力所打动——所有这些都与Wellma的愿景完美契合。Jan和Rinat完美地代表了企业家精神、深厚的专业知识、成长的意愿以及对创新和质量的高度关注。整个 Wellma 团队期待与他们和整个 PlantaCorp 团队合作，继续为我们的客户推动创新和卓越。这对 Wellma 来说是一个很好的补充，带来了新的功能并开辟了许多合作领域，这将使我们都变得更强大：1+1 >3。我们共同期待未来”。

与 PlantaCorp 的联盟进一步巩固了 Wellma 在营养保健品和药品开发和生产方面的欧洲领导者地位，通过联合顶级创业公司为其客户提供先进的能力和高质量的产品。

关于 Wellma：Wellma 是营养保健品和药品开发和生产的欧洲领导者，生产基地遍布欧洲大陆，拥有全球客户群，并以 €120M+ 的销售额快速增长。Wellma 专注于质量、灵活性和创新，为营养保健品和制药领域的领先企业提供 B2B 开发和生产服务。

关于PlantaCorp：PlantaCorp是一家领先的德国研发和制造公司，专门从事液体形式的脂质体技术，为B2B营养保健品客户提供技术和专业知识，以创造他们自己的高生物利用度脂质体配方。PlantaCorp 致力于先进的研究、质量和尖端生产，帮助品牌向消费者提供有效且经过科学验证的产品。

Stockholm, Sweden. Wellma, a leading European development and production partner in the nutraceutical and pharmaceutical sectors, announces its strategic partnership with PlantaCorp, a German CDMO and leading innovator in liposomal technology for liquid formulations.

Based in Hamburg, Germany, PlantaCorp is known for its cutting-edge R&D and proprietary liposomal encapsulation technology, which enhances the bioavailability of active ingredients. Liposomal formulations improve nutrient absorption by protecting the active compounds in phospholipid layers, allowing for higher efficacy and better outcomes for the consumer. With a strong scientific foundation, a commitment to quality, and advanced manufacturing operations, PlantaCorp has built a reputation as a trusted partner for brands in the nutraceutical sector.

“We are excited about the opportunities this partnership will bring,” said Jan Braband, co-founder and CEO at PlantaCorp. “By joining forces with Wellma, we can expand our reach, accelerate innovation, and team up to be able to grow even faster while we create even more value for our customers.”
The partnership also represents an alignment of personal values and entrepreneurial culture, as Rinat Albetkov, co-founder of PlantaCorp, highlights the strong cultural and strategic fit: “From our first conversations with Wellma, we saw a shared vision for innovation, people, entrepreneurship and sustainable growth. This partnership ensures that our technology, expertise, and entrepreneurial culture continue to thrive while also opening up exciting new opportunities for us.”

Christian Merup, CEO of Wellma, shares the excitement: “We are delighted to welcome PlantaCorp into the Wellma family. From the very beginning, we have been impressed by their advanced R&D expertise, their vision, and their strong entrepreneurial capabilities — all of which align perfectly with Wellma’s vision. Jan and Rinat perfectly represent entrepreneurship, deep expertise, willingness to grow and high focus on innovation & quality. The whole Wellma team looks forward to teaming up with them and the entire PlantaCorp team to continue driving innovation and excellence for our customers. This is a great addition for Wellma, bringing new capabilities and opening many areas for collaboration that will make us all stronger: 1+1 >3. We look forward to the future together”.

The alliance with PlantaCorp further strengthens Wellma’s position as European leader in the development and production of nutraceuticals and pharmaceuticals, by uniting top entrepreneurial companies to offer advanced capabilities and high-quality products to its customers.

About Wellma: Wellma is a European leader in development and production of nutraceuticals and pharmaceuticals with production sites across the European continent, a global customer base, and fast-growing with €120M+ in sales. With focus on quality, flexibility and innovation, Wellma offers B2B development and production services to leading actors in the nutraceutical and pharmaceutical space.

About PlantaCorp: PlantaCorp is a leading German-based R&D and manufacturing company specialized on liposomal technology in liquid form, offering B2B nutraceutical customers the technology and expertise to create their own high-bioavailability liposomal formulations. With a commitment to advanced research, quality, and cutting-edge production, PlantaCorp helps brands deliver effective and scientifically validated products to consumers.